Lobbying registration dated 2026-03-31
Registrant: Yves-Alexandre Comeau
Client: Imperial Tobacco Canada Limited
Targeted institutions:
Atlantic Canada Opportunities Agency (ACOA)
Rural Economic Development (Minister’s Office)
Finance Canada (FIN)
Office of the Quebec Lieutenant
Prime Minister's Office (PMO)
House of Commons
Public Health Agency of Canada (PHAC)
Acts: Food and Drugs Act
Government funding received:
Lobbying activity details:
5) Promoting policy and regulatory approaches that support innovation in smoking cessation
7) Identifying opportunities to engage in consultations, policy reviews, or federal programs relevant to smoking cessation or health innovation.
1) Regulations related to nicotine replacement therapies approved by Health Canada under the Food and Drugs Act (FDA).
4) Facilitating engagement with Members of Parliament, political staff, and relevant officials at Health Canada, Finance Canada, and the Privy Council Office
Targeted Public Office Holders
2) Support Imperial Tobacco Canada's public policy engagement strategy related to Zonnic, a nicotine pouch approved by Health Canada.
3) discuss Zonnic as part of a broader harm reduction framework and to promote the role of regulated nicotine replacement therapies (NRTs) in helping adult smokers quit combustible tobacco.
6) Providing timely information and scientific context related to harm reduction and nicotine pouches;